Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
Paul J. Fudala, Ph.D., T. Peter Bridge, M.D., Susan Herbert, M.A., William O. Williford, Ph.D., C. Nora Chiang, Ph.D., Karen Jones, M.S., Joseph Collins, Sc.D., Dennis Raisch, Ph.D., Paul Casadonte, M.D., R. Jeffrey Goldsmith, M.D., Walter Ling, M.D., Usha Malkerneker, M.D., Laura McNicholas, M.D., Ph.D., John Renner, M.D., Susan Stine, M.D., Ph.D., Donald Tusel, M.D., for the Buprenorphine/Naloxone Collaborative Study Group
N Engl J Med 2003; 349:2567-2568 *PDF [107 kB]